Traditional Chinese Medicine Targeting Sarcoma Virus Oncogene-related Diseases

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Sarcoma virus oncogene (Src) tyrosine kinase is vital for cell functions and implicated in inflammation and bone diseases.
• Existing Src inhibitors have clinical applications but pose risks like cardiovascular toxicity.
• There is a critical need for safer and effective Src inhibitors.

Purpose of the Study:

• To review natural compounds and Traditional Chinese Medicine (TCM) extracts with potential anti-Src activity.
• To highlight TCM as a valuable resource for discovering new Src inhibitors.

Main Methods:

• Literature review of scientific studies on Src tyrosine kinase.
• Exploration of Traditional Chinese Medicine (TCM) databases and research papers.
• Identification of natural compounds and extracts with reported anti-Src properties.

Main Results:

• Numerous natural compounds and TCM extracts demonstrate inhibitory effects on Src tyrosine kinase.
• These natural agents offer a diverse chemical scaffold for drug development.
• TCM presents a rich, largely untapped resource for novel therapeutic strategies against Src-related conditions.

Conclusions:

• Traditional Chinese Medicine (TCM) offers a promising avenue for identifying novel Src inhibitors.
• Natural compounds from TCM may provide safer alternatives to existing Src inhibitors.
• Further research into TCM-derived compounds could lead to new treatments for Src-associated diseases.